Pharma & Healthcare
Transdermal Scopolamine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 553106
- Pages: 108
- Figures: 204
- Views: 1
The global market for Transdermal Scopolamine was estimated to be worth US$ 390.5 million in 2023 and is forecast to a readjusted size of US$ 539.4 million by 2030 with a CAGR of 4.6% during the forecast period 2024-2030
North American market for Transdermal Scopolamine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Scopolamine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Transdermal Scopolamine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Transdermal Scopolamine include Baxter International, GlaxoSmithKline, Novartis AG, Perrigo Company, Caleb Pharmaceuticals, Myungmoon Pharma, Pfizer and Nichi-Iko, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Scopolamine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Transdermal Scopolamine by region & country, by Type, and by Application.
The Transdermal Scopolamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Scopolamine.
Market Segmentation
By Company
Baxter International
GlaxoSmithKline
Novartis AG
Perrigo Company
Caleb Pharmaceuticals
Myungmoon Pharma
Pfizer
Nichi-Iko
Segment by Type:
Tablet Type
Syrups Type
Injections Type
Patch Type
Gel Type
Segment by Application
Narcotic Analgesia
Cough
Asthma
Motion Sickness
Parkinson's Disease
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transdermal Scopolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Transdermal Scopolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Transdermal Scopolamine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Transdermal Scopolamine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Scopolamine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Transdermal Scopolamine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Transdermal Scopolamine include Baxter International, GlaxoSmithKline, Novartis AG, Perrigo Company, Caleb Pharmaceuticals, Myungmoon Pharma, Pfizer and Nichi-Iko, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Scopolamine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Transdermal Scopolamine by region & country, by Type, and by Application.
The Transdermal Scopolamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Scopolamine.
Market Segmentation
By Company
Baxter International
GlaxoSmithKline
Novartis AG
Perrigo Company
Caleb Pharmaceuticals
Myungmoon Pharma
Pfizer
Nichi-Iko
Segment by Type:
Tablet Type
Syrups Type
Injections Type
Patch Type
Gel Type
Segment by Application
Narcotic Analgesia
Cough
Asthma
Motion Sickness
Parkinson's Disease
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transdermal Scopolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Transdermal Scopolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Transdermal Scopolamine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Transdermal Scopolamine Product Introduction
1.2 Global Transdermal Scopolamine Market Size Forecast
1.2.1 Global Transdermal Scopolamine Sales Value (2019-2030)
1.2.2 Global Transdermal Scopolamine Sales Volume (2019-2030)
1.2.3 Global Transdermal Scopolamine Sales Price (2019-2030)
1.3 Transdermal Scopolamine Market Trends & Drivers
1.3.1 Transdermal Scopolamine Industry Trends
1.3.2 Transdermal Scopolamine Market Drivers & Opportunity
1.3.3 Transdermal Scopolamine Market Challenges
1.3.4 Transdermal Scopolamine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transdermal Scopolamine Players Revenue Ranking (2023)
2.2 Global Transdermal Scopolamine Revenue by Company (2019-2024)
2.3 Global Transdermal Scopolamine Players Sales Volume Ranking (2023)
2.4 Global Transdermal Scopolamine Sales Volume by Company Players (2019-2024)
2.5 Global Transdermal Scopolamine Average Price by Company (2019-2024)
2.6 Key Manufacturers Transdermal Scopolamine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Transdermal Scopolamine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Transdermal Scopolamine
2.9 Transdermal Scopolamine Market Competitive Analysis
2.9.1 Transdermal Scopolamine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Transdermal Scopolamine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Scopolamine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablet Type
3.1.2 Syrups Type
3.1.3 Injections Type
3.1.4 Patch Type
3.1.5 Gel Type
3.2 Global Transdermal Scopolamine Sales Value by Type
3.2.1 Global Transdermal Scopolamine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Transdermal Scopolamine Sales Value, by Type (2019-2030)
3.2.3 Global Transdermal Scopolamine Sales Value, by Type (%) (2019-2030)
3.3 Global Transdermal Scopolamine Sales Volume by Type
3.3.1 Global Transdermal Scopolamine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Transdermal Scopolamine Sales Volume, by Type (2019-2030)
3.3.3 Global Transdermal Scopolamine Sales Volume, by Type (%) (2019-2030)
3.4 Global Transdermal Scopolamine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Narcotic Analgesia
4.1.2 Cough
4.1.3 Asthma
4.1.4 Motion Sickness
4.1.5 Parkinson's Disease
4.1.6 Others
4.2 Global Transdermal Scopolamine Sales Value by Application
4.2.1 Global Transdermal Scopolamine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Transdermal Scopolamine Sales Value, by Application (2019-2030)
4.2.3 Global Transdermal Scopolamine Sales Value, by Application (%) (2019-2030)
4.3 Global Transdermal Scopolamine Sales Volume by Application
4.3.1 Global Transdermal Scopolamine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Transdermal Scopolamine Sales Volume, by Application (2019-2030)
4.3.3 Global Transdermal Scopolamine Sales Volume, by Application (%) (2019-2030)
4.4 Global Transdermal Scopolamine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Transdermal Scopolamine Sales Value by Region
5.1.1 Global Transdermal Scopolamine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Transdermal Scopolamine Sales Value by Region (2019-2024)
5.1.3 Global Transdermal Scopolamine Sales Value by Region (2025-2030)
5.1.4 Global Transdermal Scopolamine Sales Value by Region (%), (2019-2030)
5.2 Global Transdermal Scopolamine Sales Volume by Region
5.2.1 Global Transdermal Scopolamine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Transdermal Scopolamine Sales Volume by Region (2019-2024)
5.2.3 Global Transdermal Scopolamine Sales Volume by Region (2025-2030)
5.2.4 Global Transdermal Scopolamine Sales Volume by Region (%), (2019-2030)
5.3 Global Transdermal Scopolamine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Transdermal Scopolamine Sales Value, 2019-2030
5.4.2 North America Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Transdermal Scopolamine Sales Value, 2019-2030
5.5.2 Europe Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Transdermal Scopolamine Sales Value, 2019-2030
5.6.2 Asia Pacific Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Transdermal Scopolamine Sales Value, 2019-2030
5.7.2 South America Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Transdermal Scopolamine Sales Value, 2019-2030
5.8.2 Middle East & Africa Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transdermal Scopolamine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Transdermal Scopolamine Sales Value
6.2.1 Key Countries/Regions Transdermal Scopolamine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Transdermal Scopolamine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Transdermal Scopolamine Sales Value, 2019-2030
6.3.2 United States Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Transdermal Scopolamine Sales Value, 2019-2030
6.4.2 Europe Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Transdermal Scopolamine Sales Value, 2019-2030
6.5.2 China Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Transdermal Scopolamine Sales Value, 2019-2030
6.6.2 Japan Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Transdermal Scopolamine Sales Value, 2019-2030
6.7.2 South Korea Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Transdermal Scopolamine Sales Value, 2019-2030
6.8.2 Southeast Asia Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Transdermal Scopolamine Sales Value, 2019-2030
6.9.2 India Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Baxter International
7.1.1 Baxter International Company Information
7.1.2 Baxter International Introduction and Business Overview
7.1.3 Baxter International Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Baxter International Transdermal Scopolamine Product Offerings
7.1.5 Baxter International Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Information
7.2.2 GlaxoSmithKline Introduction and Business Overview
7.2.3 GlaxoSmithKline Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GlaxoSmithKline Transdermal Scopolamine Product Offerings
7.2.5 GlaxoSmithKline Recent Development
7.3 Novartis AG
7.3.1 Novartis AG Company Information
7.3.2 Novartis AG Introduction and Business Overview
7.3.3 Novartis AG Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Novartis AG Transdermal Scopolamine Product Offerings
7.3.5 Novartis AG Recent Development
7.4 Perrigo Company
7.4.1 Perrigo Company Company Information
7.4.2 Perrigo Company Introduction and Business Overview
7.4.3 Perrigo Company Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Perrigo Company Transdermal Scopolamine Product Offerings
7.4.5 Perrigo Company Recent Development
7.5 Caleb Pharmaceuticals
7.5.1 Caleb Pharmaceuticals Company Information
7.5.2 Caleb Pharmaceuticals Introduction and Business Overview
7.5.3 Caleb Pharmaceuticals Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Caleb Pharmaceuticals Transdermal Scopolamine Product Offerings
7.5.5 Caleb Pharmaceuticals Recent Development
7.6 Myungmoon Pharma
7.6.1 Myungmoon Pharma Company Information
7.6.2 Myungmoon Pharma Introduction and Business Overview
7.6.3 Myungmoon Pharma Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Myungmoon Pharma Transdermal Scopolamine Product Offerings
7.6.5 Myungmoon Pharma Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Information
7.7.2 Pfizer Introduction and Business Overview
7.7.3 Pfizer Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Pfizer Transdermal Scopolamine Product Offerings
7.7.5 Pfizer Recent Development
7.8 Nichi-Iko
7.8.1 Nichi-Iko Company Information
7.8.2 Nichi-Iko Introduction and Business Overview
7.8.3 Nichi-Iko Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Nichi-Iko Transdermal Scopolamine Product Offerings
7.8.5 Nichi-Iko Recent Development
8 Industry Chain Analysis
8.1 Transdermal Scopolamine Industrial Chain
8.2 Transdermal Scopolamine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Transdermal Scopolamine Sales Model
8.5.2 Sales Channel
8.5.3 Transdermal Scopolamine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Transdermal Scopolamine Product Introduction
1.2 Global Transdermal Scopolamine Market Size Forecast
1.2.1 Global Transdermal Scopolamine Sales Value (2019-2030)
1.2.2 Global Transdermal Scopolamine Sales Volume (2019-2030)
1.2.3 Global Transdermal Scopolamine Sales Price (2019-2030)
1.3 Transdermal Scopolamine Market Trends & Drivers
1.3.1 Transdermal Scopolamine Industry Trends
1.3.2 Transdermal Scopolamine Market Drivers & Opportunity
1.3.3 Transdermal Scopolamine Market Challenges
1.3.4 Transdermal Scopolamine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transdermal Scopolamine Players Revenue Ranking (2023)
2.2 Global Transdermal Scopolamine Revenue by Company (2019-2024)
2.3 Global Transdermal Scopolamine Players Sales Volume Ranking (2023)
2.4 Global Transdermal Scopolamine Sales Volume by Company Players (2019-2024)
2.5 Global Transdermal Scopolamine Average Price by Company (2019-2024)
2.6 Key Manufacturers Transdermal Scopolamine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Transdermal Scopolamine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Transdermal Scopolamine
2.9 Transdermal Scopolamine Market Competitive Analysis
2.9.1 Transdermal Scopolamine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Transdermal Scopolamine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Scopolamine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablet Type
3.1.2 Syrups Type
3.1.3 Injections Type
3.1.4 Patch Type
3.1.5 Gel Type
3.2 Global Transdermal Scopolamine Sales Value by Type
3.2.1 Global Transdermal Scopolamine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Transdermal Scopolamine Sales Value, by Type (2019-2030)
3.2.3 Global Transdermal Scopolamine Sales Value, by Type (%) (2019-2030)
3.3 Global Transdermal Scopolamine Sales Volume by Type
3.3.1 Global Transdermal Scopolamine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Transdermal Scopolamine Sales Volume, by Type (2019-2030)
3.3.3 Global Transdermal Scopolamine Sales Volume, by Type (%) (2019-2030)
3.4 Global Transdermal Scopolamine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Narcotic Analgesia
4.1.2 Cough
4.1.3 Asthma
4.1.4 Motion Sickness
4.1.5 Parkinson's Disease
4.1.6 Others
4.2 Global Transdermal Scopolamine Sales Value by Application
4.2.1 Global Transdermal Scopolamine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Transdermal Scopolamine Sales Value, by Application (2019-2030)
4.2.3 Global Transdermal Scopolamine Sales Value, by Application (%) (2019-2030)
4.3 Global Transdermal Scopolamine Sales Volume by Application
4.3.1 Global Transdermal Scopolamine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Transdermal Scopolamine Sales Volume, by Application (2019-2030)
4.3.3 Global Transdermal Scopolamine Sales Volume, by Application (%) (2019-2030)
4.4 Global Transdermal Scopolamine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Transdermal Scopolamine Sales Value by Region
5.1.1 Global Transdermal Scopolamine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Transdermal Scopolamine Sales Value by Region (2019-2024)
5.1.3 Global Transdermal Scopolamine Sales Value by Region (2025-2030)
5.1.4 Global Transdermal Scopolamine Sales Value by Region (%), (2019-2030)
5.2 Global Transdermal Scopolamine Sales Volume by Region
5.2.1 Global Transdermal Scopolamine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Transdermal Scopolamine Sales Volume by Region (2019-2024)
5.2.3 Global Transdermal Scopolamine Sales Volume by Region (2025-2030)
5.2.4 Global Transdermal Scopolamine Sales Volume by Region (%), (2019-2030)
5.3 Global Transdermal Scopolamine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Transdermal Scopolamine Sales Value, 2019-2030
5.4.2 North America Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Transdermal Scopolamine Sales Value, 2019-2030
5.5.2 Europe Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Transdermal Scopolamine Sales Value, 2019-2030
5.6.2 Asia Pacific Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Transdermal Scopolamine Sales Value, 2019-2030
5.7.2 South America Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Transdermal Scopolamine Sales Value, 2019-2030
5.8.2 Middle East & Africa Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transdermal Scopolamine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Transdermal Scopolamine Sales Value
6.2.1 Key Countries/Regions Transdermal Scopolamine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Transdermal Scopolamine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Transdermal Scopolamine Sales Value, 2019-2030
6.3.2 United States Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Transdermal Scopolamine Sales Value, 2019-2030
6.4.2 Europe Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Transdermal Scopolamine Sales Value, 2019-2030
6.5.2 China Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Transdermal Scopolamine Sales Value, 2019-2030
6.6.2 Japan Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Transdermal Scopolamine Sales Value, 2019-2030
6.7.2 South Korea Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Transdermal Scopolamine Sales Value, 2019-2030
6.8.2 Southeast Asia Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Transdermal Scopolamine Sales Value, 2019-2030
6.9.2 India Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Transdermal Scopolamine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Baxter International
7.1.1 Baxter International Company Information
7.1.2 Baxter International Introduction and Business Overview
7.1.3 Baxter International Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Baxter International Transdermal Scopolamine Product Offerings
7.1.5 Baxter International Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Information
7.2.2 GlaxoSmithKline Introduction and Business Overview
7.2.3 GlaxoSmithKline Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GlaxoSmithKline Transdermal Scopolamine Product Offerings
7.2.5 GlaxoSmithKline Recent Development
7.3 Novartis AG
7.3.1 Novartis AG Company Information
7.3.2 Novartis AG Introduction and Business Overview
7.3.3 Novartis AG Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Novartis AG Transdermal Scopolamine Product Offerings
7.3.5 Novartis AG Recent Development
7.4 Perrigo Company
7.4.1 Perrigo Company Company Information
7.4.2 Perrigo Company Introduction and Business Overview
7.4.3 Perrigo Company Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Perrigo Company Transdermal Scopolamine Product Offerings
7.4.5 Perrigo Company Recent Development
7.5 Caleb Pharmaceuticals
7.5.1 Caleb Pharmaceuticals Company Information
7.5.2 Caleb Pharmaceuticals Introduction and Business Overview
7.5.3 Caleb Pharmaceuticals Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Caleb Pharmaceuticals Transdermal Scopolamine Product Offerings
7.5.5 Caleb Pharmaceuticals Recent Development
7.6 Myungmoon Pharma
7.6.1 Myungmoon Pharma Company Information
7.6.2 Myungmoon Pharma Introduction and Business Overview
7.6.3 Myungmoon Pharma Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Myungmoon Pharma Transdermal Scopolamine Product Offerings
7.6.5 Myungmoon Pharma Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Information
7.7.2 Pfizer Introduction and Business Overview
7.7.3 Pfizer Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Pfizer Transdermal Scopolamine Product Offerings
7.7.5 Pfizer Recent Development
7.8 Nichi-Iko
7.8.1 Nichi-Iko Company Information
7.8.2 Nichi-Iko Introduction and Business Overview
7.8.3 Nichi-Iko Transdermal Scopolamine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Nichi-Iko Transdermal Scopolamine Product Offerings
7.8.5 Nichi-Iko Recent Development
8 Industry Chain Analysis
8.1 Transdermal Scopolamine Industrial Chain
8.2 Transdermal Scopolamine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Transdermal Scopolamine Sales Model
8.5.2 Sales Channel
8.5.3 Transdermal Scopolamine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Transdermal Scopolamine Market Trends
Table 2. Transdermal Scopolamine Market Drivers & Opportunity
Table 3. Transdermal Scopolamine Market Challenges
Table 4. Transdermal Scopolamine Market Restraints
Table 5. Global Transdermal Scopolamine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Transdermal Scopolamine Revenue Market Share by Company (2019-2024)
Table 7. Global Transdermal Scopolamine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Transdermal Scopolamine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Transdermal Scopolamine Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Transdermal Scopolamine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Transdermal Scopolamine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Transdermal Scopolamine
Table 13. Global Transdermal Scopolamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Scopolamine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Transdermal Scopolamine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Transdermal Scopolamine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Transdermal Scopolamine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Transdermal Scopolamine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Transdermal Scopolamine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Transdermal Scopolamine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Transdermal Scopolamine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Transdermal Scopolamine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Transdermal Scopolamine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Transdermal Scopolamine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Transdermal Scopolamine Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Transdermal Scopolamine Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Transdermal Scopolamine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Transdermal Scopolamine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Transdermal Scopolamine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Transdermal Scopolamine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Transdermal Scopolamine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Transdermal Scopolamine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Transdermal Scopolamine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Transdermal Scopolamine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Transdermal Scopolamine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Transdermal Scopolamine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Transdermal Scopolamine Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Transdermal Scopolamine Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Transdermal Scopolamine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Transdermal Scopolamine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Transdermal Scopolamine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Transdermal Scopolamine Sales Value by Region (2019-2024) & (%)
Table 44. Global Transdermal Scopolamine Sales Value by Region (2025-2030) & (%)
Table 45. Global Transdermal Scopolamine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Transdermal Scopolamine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Transdermal Scopolamine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Transdermal Scopolamine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Transdermal Scopolamine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Transdermal Scopolamine Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Transdermal Scopolamine Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Transdermal Scopolamine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Transdermal Scopolamine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Transdermal Scopolamine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Transdermal Scopolamine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Transdermal Scopolamine Sales Volume, (2025-2030) & (K Units)
Table 57. Baxter International Company Information
Table 58. Baxter International Introduction and Business Overview
Table 59. Baxter International Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Baxter International Transdermal Scopolamine Product Offerings
Table 61. Baxter International Recent Development
Table 62. GlaxoSmithKline Company Information
Table 63. GlaxoSmithKline Introduction and Business Overview
Table 64. GlaxoSmithKline Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. GlaxoSmithKline Transdermal Scopolamine Product Offerings
Table 66. GlaxoSmithKline Recent Development
Table 67. Novartis AG Company Information
Table 68. Novartis AG Introduction and Business Overview
Table 69. Novartis AG Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Novartis AG Transdermal Scopolamine Product Offerings
Table 71. Novartis AG Recent Development
Table 72. Perrigo Company Company Information
Table 73. Perrigo Company Introduction and Business Overview
Table 74. Perrigo Company Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Perrigo Company Transdermal Scopolamine Product Offerings
Table 76. Perrigo Company Recent Development
Table 77. Caleb Pharmaceuticals Company Information
Table 78. Caleb Pharmaceuticals Introduction and Business Overview
Table 79. Caleb Pharmaceuticals Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Caleb Pharmaceuticals Transdermal Scopolamine Product Offerings
Table 81. Caleb Pharmaceuticals Recent Development
Table 82. Myungmoon Pharma Company Information
Table 83. Myungmoon Pharma Introduction and Business Overview
Table 84. Myungmoon Pharma Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Myungmoon Pharma Transdermal Scopolamine Product Offerings
Table 86. Myungmoon Pharma Recent Development
Table 87. Pfizer Company Information
Table 88. Pfizer Introduction and Business Overview
Table 89. Pfizer Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Pfizer Transdermal Scopolamine Product Offerings
Table 91. Pfizer Recent Development
Table 92. Nichi-Iko Company Information
Table 93. Nichi-Iko Introduction and Business Overview
Table 94. Nichi-Iko Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Nichi-Iko Transdermal Scopolamine Product Offerings
Table 96. Nichi-Iko Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Transdermal Scopolamine Downstream Customers
Table 100. Transdermal Scopolamine Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Scopolamine Product Picture
Figure 2. Global Transdermal Scopolamine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Transdermal Scopolamine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Transdermal Scopolamine Sales Price (2019-2030) & (USD/Unit)
Figure 6. Transdermal Scopolamine Report Years Considered
Figure 7. Global Transdermal Scopolamine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Transdermal Scopolamine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Scopolamine Revenue in 2023
Figure 10. Transdermal Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Tablet Type Picture
Figure 12. Syrups Type Picture
Figure 13. Injections Type Picture
Figure 14. Patch Type Picture
Figure 15. Gel Type Picture
Figure 16. Global Transdermal Scopolamine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Transdermal Scopolamine Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Transdermal Scopolamine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 19. Global Transdermal Scopolamine Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Transdermal Scopolamine Price by Type (2019-2030) & (USD/Unit)
Figure 21. Product Picture of Narcotic Analgesia
Figure 22. Product Picture of Cough
Figure 23. Product Picture of Asthma
Figure 24. Product Picture of Motion Sickness
Figure 25. Product Picture of Parkinson's Disease
Figure 26. Product Picture of Others
Figure 27. Global Transdermal Scopolamine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Transdermal Scopolamine Sales Value Market Share by Application, 2023 & 2030
Figure 29. Global Transdermal Scopolamine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 30. Global Transdermal Scopolamine Sales Volume Market Share by Application, 2023 & 2030
Figure 31. Global Transdermal Scopolamine Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 33. North America Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
Figure 34. Europe Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 35. Europe Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
Figure 36. Asia Pacific Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
Figure 38. South America Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 39. South America Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
Figure 40. Middle East & Africa Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
Figure 42. Key Countries/Regions Transdermal Scopolamine Sales Value (%), (2019-2030)
Figure 43. Key Countries/Regions Transdermal Scopolamine Sales Volume (%), (2019-2030)
Figure 44. United States Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 45. United States Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 46. United States Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 47. Europe Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 48. Europe Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 49. Europe Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 50. China Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 51. China Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 52. China Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 53. Japan Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 54. Japan Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 55. Japan Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 56. South Korea Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 57. South Korea Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 58. South Korea Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 59. Southeast Asia Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 60. Southeast Asia Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 61. Southeast Asia Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 62. India Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 63. India Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 64. India Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 65. Transdermal Scopolamine Industrial Chain
Figure 66. Transdermal Scopolamine Manufacturing Cost Structure
Figure 67. Channels of Distribution (Direct Sales, and Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Transdermal Scopolamine Market Trends
Table 2. Transdermal Scopolamine Market Drivers & Opportunity
Table 3. Transdermal Scopolamine Market Challenges
Table 4. Transdermal Scopolamine Market Restraints
Table 5. Global Transdermal Scopolamine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Transdermal Scopolamine Revenue Market Share by Company (2019-2024)
Table 7. Global Transdermal Scopolamine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Transdermal Scopolamine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Transdermal Scopolamine Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Transdermal Scopolamine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Transdermal Scopolamine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Transdermal Scopolamine
Table 13. Global Transdermal Scopolamine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Scopolamine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Transdermal Scopolamine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Transdermal Scopolamine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Transdermal Scopolamine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Transdermal Scopolamine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Transdermal Scopolamine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Transdermal Scopolamine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Transdermal Scopolamine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Transdermal Scopolamine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Transdermal Scopolamine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Transdermal Scopolamine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Transdermal Scopolamine Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Transdermal Scopolamine Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Transdermal Scopolamine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Transdermal Scopolamine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Transdermal Scopolamine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Transdermal Scopolamine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Transdermal Scopolamine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Transdermal Scopolamine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Transdermal Scopolamine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Transdermal Scopolamine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Transdermal Scopolamine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Transdermal Scopolamine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Transdermal Scopolamine Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Transdermal Scopolamine Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Transdermal Scopolamine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Transdermal Scopolamine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Transdermal Scopolamine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Transdermal Scopolamine Sales Value by Region (2019-2024) & (%)
Table 44. Global Transdermal Scopolamine Sales Value by Region (2025-2030) & (%)
Table 45. Global Transdermal Scopolamine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Transdermal Scopolamine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Transdermal Scopolamine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Transdermal Scopolamine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Transdermal Scopolamine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Transdermal Scopolamine Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Transdermal Scopolamine Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Transdermal Scopolamine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Transdermal Scopolamine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Transdermal Scopolamine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Transdermal Scopolamine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Transdermal Scopolamine Sales Volume, (2025-2030) & (K Units)
Table 57. Baxter International Company Information
Table 58. Baxter International Introduction and Business Overview
Table 59. Baxter International Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Baxter International Transdermal Scopolamine Product Offerings
Table 61. Baxter International Recent Development
Table 62. GlaxoSmithKline Company Information
Table 63. GlaxoSmithKline Introduction and Business Overview
Table 64. GlaxoSmithKline Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. GlaxoSmithKline Transdermal Scopolamine Product Offerings
Table 66. GlaxoSmithKline Recent Development
Table 67. Novartis AG Company Information
Table 68. Novartis AG Introduction and Business Overview
Table 69. Novartis AG Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Novartis AG Transdermal Scopolamine Product Offerings
Table 71. Novartis AG Recent Development
Table 72. Perrigo Company Company Information
Table 73. Perrigo Company Introduction and Business Overview
Table 74. Perrigo Company Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Perrigo Company Transdermal Scopolamine Product Offerings
Table 76. Perrigo Company Recent Development
Table 77. Caleb Pharmaceuticals Company Information
Table 78. Caleb Pharmaceuticals Introduction and Business Overview
Table 79. Caleb Pharmaceuticals Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Caleb Pharmaceuticals Transdermal Scopolamine Product Offerings
Table 81. Caleb Pharmaceuticals Recent Development
Table 82. Myungmoon Pharma Company Information
Table 83. Myungmoon Pharma Introduction and Business Overview
Table 84. Myungmoon Pharma Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Myungmoon Pharma Transdermal Scopolamine Product Offerings
Table 86. Myungmoon Pharma Recent Development
Table 87. Pfizer Company Information
Table 88. Pfizer Introduction and Business Overview
Table 89. Pfizer Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Pfizer Transdermal Scopolamine Product Offerings
Table 91. Pfizer Recent Development
Table 92. Nichi-Iko Company Information
Table 93. Nichi-Iko Introduction and Business Overview
Table 94. Nichi-Iko Transdermal Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Nichi-Iko Transdermal Scopolamine Product Offerings
Table 96. Nichi-Iko Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Transdermal Scopolamine Downstream Customers
Table 100. Transdermal Scopolamine Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Scopolamine Product Picture
Figure 2. Global Transdermal Scopolamine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Transdermal Scopolamine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Transdermal Scopolamine Sales Price (2019-2030) & (USD/Unit)
Figure 6. Transdermal Scopolamine Report Years Considered
Figure 7. Global Transdermal Scopolamine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Transdermal Scopolamine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Scopolamine Revenue in 2023
Figure 10. Transdermal Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Tablet Type Picture
Figure 12. Syrups Type Picture
Figure 13. Injections Type Picture
Figure 14. Patch Type Picture
Figure 15. Gel Type Picture
Figure 16. Global Transdermal Scopolamine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Transdermal Scopolamine Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Transdermal Scopolamine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 19. Global Transdermal Scopolamine Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Transdermal Scopolamine Price by Type (2019-2030) & (USD/Unit)
Figure 21. Product Picture of Narcotic Analgesia
Figure 22. Product Picture of Cough
Figure 23. Product Picture of Asthma
Figure 24. Product Picture of Motion Sickness
Figure 25. Product Picture of Parkinson's Disease
Figure 26. Product Picture of Others
Figure 27. Global Transdermal Scopolamine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Transdermal Scopolamine Sales Value Market Share by Application, 2023 & 2030
Figure 29. Global Transdermal Scopolamine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 30. Global Transdermal Scopolamine Sales Volume Market Share by Application, 2023 & 2030
Figure 31. Global Transdermal Scopolamine Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 33. North America Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
Figure 34. Europe Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 35. Europe Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
Figure 36. Asia Pacific Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
Figure 38. South America Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 39. South America Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
Figure 40. Middle East & Africa Transdermal Scopolamine Sales Value (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Transdermal Scopolamine Sales Value by Country (%), 2023 VS 2030
Figure 42. Key Countries/Regions Transdermal Scopolamine Sales Value (%), (2019-2030)
Figure 43. Key Countries/Regions Transdermal Scopolamine Sales Volume (%), (2019-2030)
Figure 44. United States Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 45. United States Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 46. United States Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 47. Europe Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 48. Europe Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 49. Europe Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 50. China Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 51. China Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 52. China Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 53. Japan Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 54. Japan Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 55. Japan Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 56. South Korea Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 57. South Korea Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 58. South Korea Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 59. Southeast Asia Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 60. Southeast Asia Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 61. Southeast Asia Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 62. India Transdermal Scopolamine Sales Value, (2019-2030) & (US$ Million)
Figure 63. India Transdermal Scopolamine Sales Value by Type (%), 2023 VS 2030
Figure 64. India Transdermal Scopolamine Sales Value by Application (%), 2023 VS 2030
Figure 65. Transdermal Scopolamine Industrial Chain
Figure 66. Transdermal Scopolamine Manufacturing Cost Structure
Figure 67. Channels of Distribution (Direct Sales, and Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232